The Impact of Obesity on Short Stem Total Hip Arthroplasty
NCT ID: NCT06430723
Last Updated: 2024-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2018-01-01
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Subsidence of Short Stem THA With DORR Type C
NCT06768541
Obesity's Impact on the Effect of Hip Arthroplasty
NCT01496716
Unilateral vs Bilateral Total Hip Arthroplasty
NCT00764335
Evaluation of a Short Femoral Stem in Total Hip Arthroplasty
NCT02743208
Radiographic Changes and Clinical Implications of Implantation of Shortened Uncemented Femoral Stems in THA
NCT05666284
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
While studies on the mid-term outcome in a general patient cohort provide excellent results in terms of the clinical and radiological outcome as well as the complication rate of short stem THA, data on its use in obese patients is still rare and not sufficiently conclusive. Some studies have found no evidence of increased subsidence in obese patients, while other studies have shown contrary trends.
In this context, the aim of this study was to investigate the relationship between BMI, postoperative subsidence and clinical outcomes in the setting of short stem THA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-obese
Body mass index \< 30 kg/m2
Total hip arthroplasty
Total hip arthroplasty using short stem via an minimally invasive anterolateral approach
Obese
Body mass index \>= 30 kg/m2
Total hip arthroplasty
Total hip arthroplasty using short stem via an minimally invasive anterolateral approach
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total hip arthroplasty
Total hip arthroplasty using short stem via an minimally invasive anterolateral approach
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. availability of preoperative and postoperative radiographs for assessment of subsidence
3. a minimum BMI of 30kg/m2 for the obese group
4. a minimum follow-up of 24 months.
Exclusion Criteria
2. incomplete clinical data
3. incomplete radiological data
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Krankenhaus Barmherzige Schwestern Linz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ordensklinikum Linz, Barmherzige Schwestern Abteilung Orthopädie
Linz, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK 1258/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.